New cancer clinical trial: First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational Studies

Published on: January 15, 2019 at 12:00PM
Condition:   Lung Cancer
Intervention:   Drug: osimertinib
Sponsor:   Vestre Viken Hospital Trust
Recruiting
http://bit.ly/2Rwqpcx